This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1997 Nov 27;337(22):1634-5.

doi: 10.1056/NEJM199711273372217.

Interferon alfa-2b and cytarabine in chronic myelogenous leukemia

T Patel, D F Roychowdhury

PMID: 9411231
DOI: 10.1056/NEJM199711273372217

Comment

Interferon alfa-2b and cytarabine in chronic myelogenous leukemia

T Patel et al. N Engl J Med. 1997.

. 1997 Nov 27;337(22):1634-5.

doi: 10.1056/NEJM199711273372217.

Authors

T Patel, D F Roychowdhury

PMID: 9411231
DOI: 10.1056/NEJM199711273372217

No abstract available

PubMed Disclaimer

Comment on

Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group.
Guilhot F, Chastang C, Michallet M, Guerci A, Harousseau JL, Maloisel F, Bouabdallah R, Guyotat D, Cheron N, Nicolini F, Abgrall JF, Tanzer J. Guilhot F, et al. N Engl J Med. 1997 Jul 24;337(4):223-9. doi: 10.1056/NEJM199707243370402. N Engl J Med. 1997. PMID: 9227927 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information